Active substanceNicotineNicotine
Similar drugsTo uncover
  • Niquitin®
    patch cutaneous 
  • Niquitin® Mini
    pills n / az. 
  • Nicorette®
    spray locally 
  • Nicorette®
    patch externally 
  • Nicorette®
    lozenges
  • Nicorette®
    pills n / az. 
  • Nicorette
    solution d / inhal. 
  • Nicorette®
    lozenges
  • Nicorette®
    pills n / az. 
  • Nicorette®
    lozenges
  • Nicorette®
    solution d / inhal. 
  • Nicorette®
    lozenges
  • Nicorette®
    lozenges
  • Nicotinell®
    pills n / az. 
  • Nicotinell®
    patch cutaneous 
  • Dosage form: & nbspsublingual tablets
    Composition:

    Composition (per one tablet):

    Active substance: nicotine-β-cyclodextrin complex 17.1 mg (this amount is equivalent to 2 mg nicotine);

    Excipients: β-cyclodextrin (Betadex) 69.55 mg, crospovidone 2.0 mg, magnesium stearate 0.9 mg, silicon dioxide colloid 0.45 mg.

    Pharmacotherapeutic group:nicotine addiction treatment
    ATX: & nbsp

    N.07.B.A   Drugs used in nicotine addiction

    N.07.B.A.01   Nicotine

    Packaging:10) - blisters (10) - packs of cardboard
    (10) - blisters (2) - packs cardboard
    (10) - blisters (3) - packs cardboard
    (10) - blisters (9) - packs cardboard
    Shelf life:3 years
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-009583/09
    Date of registration:25.11.2009
    The owner of the registration certificate:Johnson & Johnson, LLC Johnson & Johnson, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.08.2015
    Illustrated instructions
      Instructions
      Up